Other Capital Market Information | 9 December 2019 08:47

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
09.12.2019 / 08:47
Dissemination of a Post-admission Duties announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

– Share buy-back – 25 ^th Interim Report

In the period from December 2, 2019 until and including December 6, 2019, a total of 186,894 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:

Day of repurchase	Aggregated volume in number of shares	Weighted average share price in EUR
02.12.2019	37,000	66.4677
03.12.2019	37,000	65.3615
04.12.2019	39,000	66.1793
05.12.2019	36,500	65.9766
06.12.2019	37,394	64.7881

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including December 6, 2019 therefore amounts to 4,729,664 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., December 9, 2019

09.12.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Fresenius Medical Care AG & Co. KGaA
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com

End of News DGAP News Service